Form 8.3 Merrion Pharmaceuticals plc disclosures 20 Oct, 2011 to 13 Feb, 2012

February 14, 2012 07:17 AM Eastern Standard Time

FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED) DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE PLEASE NOTE: This disclosure form covers all dealings to be disclosed under Rule 8.3 from 20 October, 2011 to 13 February, 2012. 1. KEY INFORMATION
Name of person dealing (Note 1)	Goodbody Stockbrokers
Company dealt in	Merrion Pharmaceuticals
Class of relevant security to which the dealings being disclosed relate (Note 2)	€0.01 ordinary shares
Date of dealing	See Appendix 1
2. INTERESTS AND SHORT POSITIONS (as at cob 13 Feb, 2012) (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
	Long	Short
	Number (%)	Number (%)
(1) Relevant securities	668,915
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total	668,915
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security:	Long	Short
	Number (%)	Number (%)
(1) Relevant securities	3.90%
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total	3.90%
1 February 2009

3. DEALINGS (Note 4)

(a) Purchases and sales

See Appendix 1 for all dealings from 20 Oct, 2011 to 13 Feb, 2012.

Purchase / sale

No. of relevant securities

Price per unit (Note 5)

(b) Derivatives transactions (other than options transactions)

Product name, e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name, e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

(ii) Exercising

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

	4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives
	Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
	None
	Is a Supplemental Form 8 attached? (Note 9) NO
	Date of disclosure		14 February, 2012
	Contact name		Tim Dyball
	Telephone number		+353 1 6416084
	If a connected EFM, name of offeree/offeror with which connected		N/A
	If a connected EFM, state nature of connection (Note 10)		N/A

Appendix 1 – All dealing from 20 Oct, 2011 to 13 Feb, 2012

Category Code: MSC

Sequence Number: 312818

Time of Receipt (offset from UTC): 20120214T121253+0000

Contacts

GOODBODY STOCKBROKERS